Evonik has developed a new osteoconductive polyether ether ketone (PEEK), VESTAKEEP® iC4800 , for the medical technology market that improves the fusion between the bone and the implant. With the introduction of the new biomaterial, Evonik is launching a new product line of next-generation, PEEK-based implant materials that it will market under the brand name VESTAKEEP® Fusion. Evonik will unveil the product at the virtual Eurospine conference October 6–9. Easy Osteointegration for Accelerated Bone Fusion The osteoconductive properties of the new PEEK material were achieved by using a special functional additive - biphasic calcium phosphate - and allow bone cells to adhere to implants more quickly, thus positively influencing fusion, so called osteointegration, at the boundary between the bone and the implant. This, in turn, will accelerate bone fusion and convalescence. As the first biomaterial in Evonik’s new Fusion product line, VESTAKEEP® iC4800 will impress customers with